Futura Medical’s profit warning leaves nagging doubts so exit now
Futura Medical (FUM:AIM) 16.5pLoss to date: 50%In October 2024, we highlighted sexual health specialist Futura Medical (FUM:AIM) as a great opportunity to get on board as it launched its ED (erectile dysfunction) product Eroxon into...
06 February 2025